1. Mutations disrupting the kinase domain of IKKα lead to immunodeficiency and immune dysregulation in humans
- Author
-
Riller, Quentin, Sorin, Boris, Courteille, Charline, Ho-Nhat, Duong, Le Voyer, Tom, Debray, Jean-Christophe, Stolzenberg, Marie-Claude, Schmutz, Muriel, Pellé, Olivier, Becquard, Thomas, Rodrigo Riestra, María, Berteloot, Laureline, Migaud, Mélanie, Delage, Laure, Jeanpierre, Marie, Boussard, Charlotte, Brunaud, Camille, Magérus, Aude, Bretot, Charles, Michel, Victor, Roux, Camille, Picard, Capucine, Masson, Cécile, Bole-Feysot, Christine, Cagnard, Nicolas, Corneau, Aurélien, Meyts, Isabelle, Baud, Véronique, Casanova, Jean-Laurent, Fischer, Alain, Dejardin, Emmanuel, Puel, Anne, Boulanger, Cécile, Neven, Bénédicte, and Rieux-Laucat, Frédéric
- Abstract
IKKα, encoded by CHUK, is crucial in the non-canonical NF-κB pathway and part of the IKK complex activating the canonical pathway alongside IKKβ. The absence of IKKα causes fetal encasement syndrome in humans, fatal in utero, while an impaired IKKα-NIK interaction was reported in a single patient and causes combined immunodeficiency. Here, we describe compound heterozygous variants in the kinase domain of IKKα in a female patient with hypogammaglobulinemia, recurrent lung infections, and Hay–Wells syndrome-like features. We showed that both variants were loss-of-function. Non-canonical NF-κB activation was profoundly diminished in stromal and immune cells while the canonical pathway was unexpectedly partially impaired. Reintroducing wt CHUK restored non-canonical NF-κB activation. The patient had neutralizing autoantibodies against type I IFN, akin to non-canonical NF-κB pathway deficiencies. Thus, this is the first case of biallelic CHUK mutations disrupting IKKα kinase function, broadening non-canonical NF-κB defect understanding, and suggesting IKKα’s role in canonical NF-κB target gene expression in humans.
- Published
- 2025
- Full Text
- View/download PDF